| positive regulation of developmental process | GO:0051094 | 314 | 0.924 | |
| transforming growth factor beta activation | GO:0036363 | 1 | 0.920 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.891 | |
| positive regulation of mesenchymal stem cell differentiation | GO:2000741 | 4 | 0.843 | |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.814 | |
| regulation of locomotion | GO:0040012 | 329 | 0.782 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.781 | Human |
| collagen metabolic process | GO:0032963 | 28 | 0.780 | |
| biological adhesion | GO:0022610 | 331 | 0.743 | |
| positive regulation of stem cell differentiation | GO:2000738 | 29 | 0.729 | |
| angiogenesis | GO:0001525 | 147 | 0.728 | |
| mesenchyme development | GO:0060485 | 59 | 0.681 | |
| multicellular organismal metabolic process | GO:0044236 | 34 | 0.669 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.661 | |
| extracellular matrix organization | GO:0030198 | 41 | 0.659 | |
| glomerular basement membrane development | GO:0032836 | 3 | 0.658 | |
| extracellular structure organization | GO:0043062 | 41 | 0.656 | |
| endoderm development | GO:0007492 | 33 | 0.625 | Human |
| cardiovascular system development | GO:0072358 | 262 | 0.571 | |
| cell adhesion | GO:0007155 | 325 | 0.553 | |
| cell development | GO:0048468 | 328 | 0.541 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.530 | |
| blood vessel development | GO:0001568 | 172 | 0.528 | |
| circulatory system development | GO:0072359 | 262 | 0.520 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.511 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 29 | 0.465 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.450 | |
| ossification | GO:0001503 | 121 | 0.442 | Human |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.416 | |
| regulation of cell migration | GO:0030334 | 289 | 0.412 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.407 | |
| sensory perception of light stimulus | GO:0050953 | 35 | 0.398 | |
| taxis | GO:0042330 | 157 | 0.393 | |
| regulation of endodermal cell differentiation | GO:1903224 | 3 | 0.391 | |
| endoderm formation | GO:0001706 | 33 | 0.374 | Human |
| stem cell differentiation | GO:0048863 | 93 | 0.366 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.363 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.359 | Human |
| vasculature development | GO:0001944 | 181 | 0.343 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.343 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.342 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 94 | 0.336 | |
| neural crest cell development | GO:0014032 | 3 | 0.330 | |
| cartilage development | GO:0051216 | 31 | 0.324 | |
| tube development | GO:0035295 | 125 | 0.323 | Human |
| connective tissue development | GO:0061448 | 39 | 0.322 | |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.300 | |
| skeletal system development | GO:0001501 | 79 | 0.295 | |
| gastrulation | GO:0007369 | 51 | 0.293 | Human |
| cellular component morphogenesis | GO:0032989 | 314 | 0.290 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.285 | |
| epithelium development | GO:0060429 | 227 | 0.271 | |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.264 | Human |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.256 | |
| cell morphogenesis | GO:0000902 | 296 | 0.253 | |
| mesenchymal stem cell proliferation | GO:0097168 | 1 | 0.245 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.240 | Rat |
| tube morphogenesis | GO:0035239 | 95 | 0.238 | Human |
| growth | GO:0040007 | 202 | 0.232 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.230 | |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.225 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.221 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.219 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.214 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.212 | |
| regulation of cell motility | GO:2000145 | 299 | 0.200 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.190 | |
| response to wounding | GO:0009611 | 168 | 0.187 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.183 | |
| chondrocyte differentiation | GO:0002062 | 17 | 0.183 | |
| visual perception | GO:0007601 | 27 | 0.179 | |
| formation of primary germ layer | GO:0001704 | 42 | 0.177 | Human |
| stem cell development | GO:0048864 | 69 | 0.176 | |
| biomineral tissue development | GO:0031214 | 39 | 0.175 | |
| chondroitin sulfate metabolic process | GO:0030204 | 7 | 0.171 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.169 | |
| bone development | GO:0060348 | 26 | 0.169 | |
| regulation of cartilage development | GO:0061035 | 12 | 0.167 | |
| negative regulation of gastrulation | GO:2000542 | 4 | 0.166 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.166 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.158 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.153 | |
| peptide cross linking | GO:0018149 | 12 | 0.147 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.139 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.138 | |
| protein oligomerization | GO:0051259 | 173 | 0.136 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.130 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.126 | Human |
| endodermal cell differentiation | GO:0035987 | 31 | 0.125 | Human |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.124 | |
| negative regulation of embryonic development | GO:0045992 | 4 | 0.123 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.122 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.121 | |
| sprouting angiogenesis | GO:0002040 | 29 | 0.119 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.118 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.117 | |
| basement membrane organization | GO:0071711 | 3 | 0.115 | |
| cell activation | GO:0001775 | 213 | 0.114 | |
| regulation of ossification | GO:0030278 | 58 | 0.114 | |
| digestive tract development | GO:0048565 | 75 | 0.113 | Human |
| response to growth factor | GO:0070848 | 205 | 0.110 | |
| soft palate development | GO:0060023 | 3 | 0.109 | |
| wound healing | GO:0042060 | 115 | 0.109 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.106 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.105 | |
| angiogenesis involved in wound healing | GO:0060055 | 4 | 0.105 | |
| digestive system development | GO:0055123 | 75 | 0.102 | Human |
| negative regulation of endodermal cell differentiation | GO:1903225 | 2 | 0.102 | |
| retina vasculature morphogenesis in camera type eye | GO:0061299 | 3 | 0.100 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.097 | |
| positive regulation of fibroblast migration | GO:0010763 | 3 | 0.097 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.097 | |
| regulation of protein localization | GO:0032880 | 296 | 0.095 | |
| detection of mechanical stimulus | GO:0050982 | 4 | 0.093 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.093 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.093 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.092 | |
| integrin mediated signaling pathway | GO:0007229 | 32 | 0.091 | |
| mucopolysaccharide metabolic process | GO:1903510 | 27 | 0.091 | |
| embryonic skeletal joint development | GO:0072498 | 2 | 0.090 | |
| cytokine production | GO:0001816 | 247 | 0.085 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.084 | |
| regulation of leukocyte chemotaxis | GO:0002688 | 46 | 0.083 | |
| sensory organ development | GO:0007423 | 52 | 0.082 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.080 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.078 | |
| cellular response to acid chemical | GO:0071229 | 44 | 0.078 | |
| regulation of leukocyte migration | GO:0002685 | 63 | 0.076 | |
| negative regulation of chondrocyte differentiation | GO:0032331 | 5 | 0.076 | |
| retina vasculature development in camera type eye | GO:0061298 | 3 | 0.076 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.073 | |
| epithelial to mesenchymal transition | GO:0001837 | 48 | 0.071 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.069 | |
| negative regulation of cell adhesion | GO:0007162 | 64 | 0.068 | |
| cellular response to amino acid stimulus | GO:0071230 | 12 | 0.067 | |
| transforming growth factor beta production | GO:0071604 | 14 | 0.067 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.065 | |
| cell matrix adhesion | GO:0007160 | 85 | 0.064 | |
| collagen fibril organization | GO:0030199 | 10 | 0.064 | |
| regulation of protein transport | GO:0051223 | 213 | 0.063 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 54 | 0.062 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.062 | |
| positive regulation of mesenchymal stem cell proliferation | GO:1902462 | 1 | 0.062 | |
| nervous system development | GO:0007399 | 293 | 0.062 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 85 | 0.060 | |
| protein maturation | GO:0051604 | 233 | 0.058 | |
| epithelial cell migration | GO:0010631 | 119 | 0.058 | |
| cell chemotaxis | GO:0060326 | 112 | 0.058 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.058 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.058 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 2 | 0.057 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.057 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.057 | |
| negative regulation of smooth muscle cell migration | GO:0014912 | 7 | 0.057 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.056 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.056 | |
| regulation of secretion | GO:0051046 | 194 | 0.056 | |
| cell projection organization | GO:0030030 | 252 | 0.054 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 45 | 0.054 | |
| replacement ossification | GO:0036075 | 1 | 0.053 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.052 | |
| semaphorin plexin signaling pathway | GO:0071526 | 4 | 0.050 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.050 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.050 | |
| endothelial cell migration | GO:0043542 | 86 | 0.050 | |
| response to radiation | GO:0009314 | 151 | 0.050 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.049 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.049 | |
| kidney development | GO:0001822 | 53 | 0.048 | |
| protein heterooligomerization | GO:0051291 | 16 | 0.048 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.047 | |
| response to lipid | GO:0033993 | 206 | 0.047 | |
| tissue migration | GO:0090130 | 119 | 0.047 | |
| endochondral bone morphogenesis | GO:0060350 | 3 | 0.046 | |
| neural crest cell migration | GO:0001755 | 2 | 0.046 | |
| mapk cascade | GO:0000165 | 288 | 0.046 | |
| sensory perception | GO:0007600 | 103 | 0.046 | |
| protein secretion | GO:0009306 | 98 | 0.045 | |
| heart development | GO:0007507 | 95 | 0.044 | |
| protein heterotrimerization | GO:0070208 | 4 | 0.044 | |
| response to metal ion | GO:0010038 | 84 | 0.044 | |
| immune system development | GO:0002520 | 195 | 0.043 | |
| pattern specification process | GO:0007389 | 43 | 0.042 | |
| patterning of blood vessels | GO:0001569 | 2 | 0.041 | |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.040 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.040 | |
| immune response | GO:0006955 | 307 | 0.039 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.039 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 2 | 0.039 | |
| protein processing | GO:0016485 | 226 | 0.038 | |
| chondroitin sulfate proteoglycan metabolic process | GO:0050654 | 10 | 0.037 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.037 | |
| organ morphogenesis | GO:0009887 | 147 | 0.037 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.036 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.036 | |
| cardiac muscle tissue development | GO:0048738 | 39 | 0.036 | |
| positive regulation of transport | GO:0051050 | 336 | 0.036 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.035 | |
| salivary gland morphogenesis | GO:0007435 | 4 | 0.035 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.035 | |
| response to acid chemical | GO:0001101 | 66 | 0.035 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 9 | 0.035 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.035 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.034 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 108 | 0.034 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.034 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.034 | |
| neuron projection regeneration | GO:0031102 | 1 | 0.034 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.033 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.033 | |
| embryo development | GO:0009790 | 123 | 0.033 | Human |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.033 | |
| regulation of angiogenesis | GO:0045765 | 92 | 0.033 | |
| neurogenesis | GO:0022008 | 169 | 0.033 | |
| regulation of blood pressure | GO:0008217 | 30 | 0.032 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.032 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.032 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.032 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.032 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.032 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.032 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 33 | 0.032 | |
| detection of abiotic stimulus | GO:0009582 | 15 | 0.032 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.032 | |
| eye development | GO:0001654 | 42 | 0.031 | |
| cell cell signaling | GO:0007267 | 155 | 0.031 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.031 | |
| muscle organ development | GO:0007517 | 56 | 0.031 | |
| regulation of growth | GO:0040008 | 165 | 0.030 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.030 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.029 | |
| platelet activation | GO:0030168 | 44 | 0.029 | |
| regulation of mesenchymal stem cell proliferation | GO:1902460 | 1 | 0.029 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.029 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.029 | |
| hemostasis | GO:0007599 | 76 | 0.029 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 24 | 0.028 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.028 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.028 | |
| leukocyte activation | GO:0045321 | 164 | 0.028 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.028 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.027 | |
| cell aging | GO:0007569 | 52 | 0.027 | |
| collagen biosynthetic process | GO:0032964 | 15 | 0.027 | |
| regeneration | GO:0031099 | 4 | 0.027 | |
| response to inorganic substance | GO:0010035 | 127 | 0.027 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.027 | |
| glycosaminoglycan metabolic process | GO:0030203 | 35 | 0.027 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.027 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.027 | |
| response to oxidative stress | GO:0006979 | 121 | 0.026 | |
| cerebellum development | GO:0021549 | 2 | 0.026 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.026 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.026 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.026 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.026 | |
| defense response | GO:0006952 | 315 | 0.026 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.026 | |
| regulation of immune response | GO:0050776 | 201 | 0.025 | |
| post embryonic development | GO:0009791 | 2 | 0.025 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.025 | |
| negative regulation of response to wounding | GO:1903035 | 47 | 0.025 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 36 | 0.025 | |
| translation | GO:0006412 | 132 | 0.024 | |
| positive regulation of protein secretion | GO:0050714 | 60 | 0.024 | |
| secretion by cell | GO:0032940 | 226 | 0.024 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 37 | 0.024 | |
| membrane organization | GO:0061024 | 292 | 0.024 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.024 | |
| central nervous system development | GO:0007417 | 123 | 0.024 | |
| muscle structure development | GO:0061061 | 98 | 0.024 | |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 2 | 0.024 | |
| negative regulation of ossification | GO:0030279 | 21 | 0.024 | |
| negative regulation of angiogenesis | GO:0016525 | 39 | 0.024 | |
| negative regulation of chemotaxis | GO:0050922 | 13 | 0.023 | |
| chromatin modification | GO:0016568 | 298 | 0.023 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.023 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.023 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 76 | 0.022 | |
| histone modification | GO:0016570 | 251 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.022 | |
| secretion | GO:0046903 | 254 | 0.022 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.022 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.022 | |
| single organism membrane organization | GO:0044802 | 268 | 0.022 | |
| neuron development | GO:0048666 | 113 | 0.022 | |
| detection of mechanical stimulus involved in sensory perception | GO:0050974 | 1 | 0.022 | |
| inflammatory response | GO:0006954 | 79 | 0.022 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.022 | |
| fibroblast proliferation | GO:0048144 | 33 | 0.022 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.021 | |
| cell junction assembly | GO:0034329 | 67 | 0.021 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.021 | |
| protein activation cascade | GO:0072376 | 22 | 0.021 | |
| positive regulation of lymphocyte activation | GO:0051251 | 73 | 0.021 | |
| chromatin organization | GO:0006325 | 351 | 0.021 | |
| negative regulation of cell migration | GO:0030336 | 102 | 0.021 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.021 | |
| endothelial cell apoptotic process | GO:0072577 | 26 | 0.020 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.020 | |
| stem cell proliferation | GO:0072089 | 25 | 0.020 | |
| response to oxygen levels | GO:0070482 | 100 | 0.020 | |
| head development | GO:0060322 | 108 | 0.020 | |
| embryonic skeletal system development | GO:0048706 | 13 | 0.020 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.020 | |
| behavior | GO:0007610 | 112 | 0.020 | |
| endochondral ossification | GO:0001958 | 1 | 0.019 | |
| regulation of bmp signaling pathway | GO:0030510 | 27 | 0.019 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.019 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.019 | |
| chemotaxis | GO:0006935 | 157 | 0.019 | |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902041 | 24 | 0.019 | |
| regulation of smooth muscle cell migration | GO:0014910 | 15 | 0.019 | |
| segmentation | GO:0035282 | 4 | 0.019 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.018 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 1 | 0.018 | |
| odontogenesis | GO:0042476 | 25 | 0.018 | |
| glomerulus development | GO:0032835 | 15 | 0.018 | |
| regulation of protein import into nucleus | GO:0042306 | 78 | 0.018 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.017 | |
| positive regulation of stem cell proliferation | GO:2000648 | 10 | 0.017 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.017 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.017 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.017 | |
| regulation of chemotaxis | GO:0050920 | 74 | 0.017 | |
| bmp signaling pathway | GO:0030509 | 49 | 0.017 | |
| transmembrane transport | GO:0055085 | 399 | 0.017 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.017 | |
| regulation of stem cell proliferation | GO:0072091 | 15 | 0.017 | |
| positive regulation of cell junction assembly | GO:1901890 | 11 | 0.017 | |
| actin filament based process | GO:0030029 | 224 | 0.017 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 25 | 0.017 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.017 | |
| myeloid leukocyte migration | GO:0097529 | 62 | 0.017 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.017 | |
| negative regulation of catabolic process | GO:0009895 | 104 | 0.017 | |
| cell substrate junction assembly | GO:0007044 | 35 | 0.017 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.017 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.016 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.016 | |
| axon regeneration | GO:0031103 | 1 | 0.016 | |
| determination of dorsal ventral asymmetry | GO:0048262 | 4 | 0.016 | |
| neuron projection development | GO:0031175 | 106 | 0.016 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 17 | 0.016 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.016 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.016 | |
| renal system development | GO:0072001 | 63 | 0.016 | |
| regulation of cell growth | GO:0001558 | 135 | 0.016 | |
| intracellular protein transport | GO:0006886 | 270 | 0.016 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.016 | |
| glycoprotein metabolic process | GO:0009100 | 110 | 0.016 | |
| positive regulation of endothelial cell apoptotic process | GO:2000353 | 8 | 0.016 | |
| regulation of myotube differentiation | GO:0010830 | 18 | 0.016 | |
| oxidative stress induced premature senescence | GO:0090403 | 3 | 0.016 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.016 | |
| response to cytokine | GO:0034097 | 232 | 0.016 | |
| activation of protein kinase activity | GO:0032147 | 90 | 0.016 | |
| lung alveolus development | GO:0048286 | 4 | 0.016 | |
| skeletal system morphogenesis | GO:0048705 | 24 | 0.016 | |
| innate immune response | GO:0045087 | 178 | 0.016 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.016 | |
| regulation of endothelial cell proliferation | GO:0001936 | 56 | 0.015 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.015 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.015 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.015 | |
| plasma membrane organization | GO:0007009 | 115 | 0.015 | |
| integrin biosynthetic process | GO:0045112 | 4 | 0.015 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.015 | |
| oogenesis | GO:0048477 | 2 | 0.015 | |
| cellular carbohydrate metabolic process | GO:0044262 | 84 | 0.015 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.015 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.015 | |
| regulation of endocytosis | GO:0030100 | 72 | 0.015 | |
| muscle cell development | GO:0055001 | 29 | 0.015 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.014 | |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.014 | |
| system process | GO:0003008 | 349 | 0.014 | |
| positive regulation of angiogenesis | GO:0045766 | 51 | 0.014 | |
| cell migration involved in kidney development | GO:0035787 | 2 | 0.014 | |
| protein catabolic process | GO:0030163 | 325 | 0.014 | |
| sulfur compound biosynthetic process | GO:0044272 | 38 | 0.014 | |
| anatomical structure regression | GO:0060033 | 1 | 0.014 | |
| embryonic organ development | GO:0048568 | 36 | 0.014 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.014 | |
| microtubule based process | GO:0007017 | 210 | 0.014 | |
| organelle assembly | GO:0070925 | 176 | 0.014 | |
| oxidation reduction process | GO:0055114 | 396 | 0.014 | |
| endomembrane system organization | GO:0010256 | 196 | 0.014 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.014 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.014 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 48 | 0.014 | |
| anterior posterior axis specification embryo | GO:0008595 | 2 | 0.014 | |
| neuron differentiation | GO:0030182 | 138 | 0.014 | |
| blood coagulation | GO:0007596 | 76 | 0.014 | |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.014 | |
| response to hypoxia | GO:0001666 | 96 | 0.013 | |
| regulation of protein kinase b signaling | GO:0051896 | 61 | 0.013 | |
| female gamete generation | GO:0007292 | 2 | 0.013 | |
| negative regulation of complement activation | GO:0045916 | 7 | 0.013 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.013 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.013 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.013 | |
| neurological system process | GO:0050877 | 163 | 0.013 | |
| negative regulation of cartilage development | GO:0061037 | 5 | 0.013 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.013 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.013 | |
| chondroitin sulfate biosynthetic process | GO:0030206 | 7 | 0.013 | |
| rhythmic behavior | GO:0007622 | 2 | 0.013 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.013 | |
| cell division | GO:0051301 | 168 | 0.013 | |
| negative regulation of purine nucleotide metabolic process | GO:1900543 | 28 | 0.013 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.013 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.013 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.013 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.013 | |
| chemical homeostasis | GO:0048878 | 306 | 0.013 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 116 | 0.013 | |
| epithelium migration | GO:0090132 | 119 | 0.013 | |
| regulation of body fluid levels | GO:0050878 | 99 | 0.013 | |
| regulation of blood coagulation | GO:0030193 | 42 | 0.013 | |
| vascular wound healing | GO:0061042 | 4 | 0.012 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.012 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.012 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.012 | |
| cellular homeostasis | GO:0019725 | 196 | 0.012 | |
| response to amino acid | GO:0043200 | 14 | 0.012 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.012 | |
| thiamine transmembrane transport | GO:0071934 | 2 | 0.012 | |
| negative regulation of kinase activity | GO:0033673 | 106 | 0.012 | |
| regulation of platelet aggregation | GO:0090330 | 4 | 0.012 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.012 | |
| monocyte chemotaxis | GO:0002548 | 20 | 0.012 | |
| metanephric nephron epithelium development | GO:0072243 | 4 | 0.012 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 37 | 0.012 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.012 | |
| sensory perception of sound | GO:0007605 | 37 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.012 | |
| regulation of wound healing | GO:0061041 | 56 | 0.012 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.012 | |
| mitotic nuclear division | GO:0007067 | 119 | 0.012 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.012 | |
| regulation of biomineral tissue development | GO:0070167 | 31 | 0.012 | |
| response to extracellular stimulus | GO:0009991 | 85 | 0.012 | |
| glomerular visceral epithelial cell development | GO:0072015 | 2 | 0.012 | |
| zymogen activation | GO:0031638 | 70 | 0.012 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.012 | |
| tooth mineralization | GO:0034505 | 6 | 0.012 | |
| regulation of vesicle mediated transport | GO:0060627 | 130 | 0.011 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.011 | |
| elastic fiber assembly | GO:0048251 | 3 | 0.011 | |
| regulation of renal albumin absorption | GO:2000532 | 1 | 0.011 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.011 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.011 | |
| regulation of behavior | GO:0050795 | 82 | 0.011 | |
| proteoglycan catabolic process | GO:0030167 | 3 | 0.011 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.011 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 12 | 0.011 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 2 | 0.011 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.011 | |
| response to camp | GO:0051591 | 25 | 0.011 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.011 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.011 | |
| epithelial cell development | GO:0002064 | 34 | 0.011 | |
| lymphocyte activation | GO:0046649 | 133 | 0.011 | |
| metencephalon development | GO:0022037 | 2 | 0.011 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.011 | |
| regulation of lymphocyte activation | GO:0051249 | 103 | 0.011 | |
| vitamin transmembrane transport | GO:0035461 | 4 | 0.011 | |
| response to retinoic acid | GO:0032526 | 33 | 0.011 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.011 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.011 | |
| positive regulation of cell cycle process | GO:0090068 | 106 | 0.011 | |
